Review



human gdf5 rhgdf5  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems human gdf5 rhgdf5
    Figure 8. 1,25D blocks <t>rhGDF5</t> induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.
    Human Gdf5 Rhgdf5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Human+GDF-5+Protein%2C+CF/pm37490334-182-25-30
    Average 93 stars, based on 11 article reviews
    human gdf5 rhgdf5 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia."

    Article Title: Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia.

    Journal: JCI insight

    doi: 10.1172/jci.insight.163259

    Figure 8. 1,25D blocks rhGDF5 induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.
    Figure Legend Snippet: Figure 8. 1,25D blocks rhGDF5 induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.

    Techniques Used: Expressing, Incubation, Western Blot, Gene Expression

    Related Articles

    Recombinant:

    Article Title: Human Chondrocytes Respond Discordantly to the Protein Encoded by the Osteoarthritis Susceptibility Gene GDF5
    Article Snippet: .. The cells were stimulated with four different recombinant GDF5 proteins (mouse GDF5, R&D Systems; human wild type GDF5 and two variants A and B, Biopharm GmbH) at 10 ng/ml, 30 ng/ml, 100 ng/ml and 300 ng/ml. .. Recombinant human TGF-β1 (5 ng/ml; R&D Systems) and BMP2 (100 ng/ml; R&D Systems) were also used as positive controls.

    Article Title: Human Chondrocytes Respond Discordantly to the Protein Encoded by the Osteoarthritis Susceptibility Gene GDF5
    Article Snippet: In addition, we used a second variant form of GDF5, also designed by Biopharm that is insensitive to the GDF5 antagonist noggin (variant B). .. Therefore, we used four different recombinant GDF5 proteins in total: wildtype mouse (R&D Systems), wildtype human (Biopharm) and the two variants, A and B. ..



    Similar Products

    93
    R&D Systems human gdf5 rhgdf5
    Figure 8. 1,25D blocks <t>rhGDF5</t> induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.
    Human Gdf5 Rhgdf5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Human+GDF-5+Protein%2C+CF/pm37490334-182-25-30
    Average 93 stars, based on 1 article reviews
    human gdf5 rhgdf5 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems Hematology gdf5
    Figure 8. 1,25D blocks <t>rhGDF5</t> induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.
    Gdf5, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Human+GDF-5+Protein%2C+CF/pm36734484-52-20-22
    Average 93 stars, based on 1 article reviews
    gdf5 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Biopharm GmbH recombinant gdf5 proteins
    Figure 8. 1,25D blocks <t>rhGDF5</t> induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.
    Recombinant Gdf5 Proteins, supplied by Biopharm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/recombinant+human+gdf+5/pmc03897745-126-14-16
    Average 90 stars, based on 1 article reviews
    recombinant gdf5 proteins - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    92
    R&D Systems human gdf5
    Figure 8. 1,25D blocks <t>rhGDF5</t> induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.
    Human Gdf5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Mouse+GDF-5+Protein/pm34517078-50-12-42
    Average 92 stars, based on 1 article reviews
    human gdf5 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    93
    R&D Systems recombi ant human gdf5
    Fig. 1. SDS-PAGE and densitometric analy- ses of cell layers of human tenocytes treated without ( − )/with ( + ) MMC (carrageenan) and without ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, <t>GDF5</t> and TGF 𝛽3 revealed that MMC supple- mentation, at all timepoints, induced signifi- cantly ( p < 0.05) higher collagen type I depo- sition than the non-MMC groups (without or even with any GF). among the simultaneous GF supplementation to MMC, TGF 𝛽3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. among the serial GF supplementation to MMC, TGF 𝛽3 induced the highest ( p < 0.05) colla- gen type I deposition in human tenocyte cul- tures at all time points. Day 4 ( A ), Day 7 ( B ), Day 10 ( C ), Day 13 ( D ). ∗ indicates significantly ( p < 0.05) higher difference between the simul- taneous and/or serial GF supplementation to MMC and MMC alone groups. Passage 3. N = 3.
    Recombi Ant Human Gdf5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Human+GDF-5+Protein%2C+CF/10__1016_slash_j__bbiosy__2021__100009-49-69-73
    Average 93 stars, based on 1 article reviews
    recombi ant human gdf5 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human gdf5
    SDS-PAGE and densitometric analyses of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , <t>GDF5</t> and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). among the simultaneous GF supplementation to MMC, TGF β 3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. among the serial GF supplementation to MMC, TGF β 3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. Day 4 ( A ), Day 7 ( B ), Day 10 ( C ), Day 13 ( D ). * indicates significantly ( p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Passage 3. N = 3.
    Recombinant Human Gdf5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Human+GDF-5+Protein%2C+CF/pmc09934496-39-64-67
    Average 93 stars, based on 1 article reviews
    recombinant human gdf5 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    R&D Systems gdf5
    FIGURE 5 (a) Regulation of Fhl2 gene expression in micromass cultures 6 h after treatments with Wnt3A and Wnt5A (a), Tgfbeta2, and inhibitor of Smad3, SIS3 (b), and all‐trans‐retinoic acid (c). (d, e) Regulation of Fhl2 in micromass cultures 24 hr after treatment with different bone morphogenetic protein (BMP) ligands (BMP4, BMP5, BMP7, and <t>GDF5;</t> d) and BMP antagonists (noggin and chordin‐like 2) or the BMP inhibitor DMH1 (e). ***p < .001; **p < .01; *p < .05 versus control. ###p < .001 between the two treatments
    Gdf5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+gdf5+proteins/Recombinant+Mouse+GDF-5+Protein/pm29330921-58-31-36
    Average 90 stars, based on 1 article reviews
    gdf5 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 8. 1,25D blocks rhGDF5 induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.

    Journal: JCI insight

    Article Title: Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia.

    doi: 10.1172/jci.insight.163259

    Figure Lengend Snippet: Figure 8. 1,25D blocks rhGDF5 induced expression of BMP and IHH genes and p-SMAD1/5 and VDR expression is decreased in Hyp entheses by P14. (A) Primary murine chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with or without (–) 1 × 10–8 M 1,25D prior to incubation with (+) or without (–) 100 ng/mL rhGDF5 (for 30 minutes) and subject- ed to Western blot analyses for p-SMAD1/5/9, SMAD1, and β-actin. Data are representative of those obtained from 3 independent experiments. (B) Primary murine chondrocytes were pretreated for 18 hours with 1 × 10–8 M 1,25D followed by treatment with 200 ng/mL rhGDF5 (for 4 hours). Gene expression analyses were performed for BMP and IHH target genes. Data are representative of those obtained from 5–7 independent experiments. One-way ANOVA followed by Fisher’s least significant difference test was used to analyze significance between all genotype groups. *P < 0.05 ver- sus WT; #P < 0.05 versus rhGDF5; a indicates P < 0.05 versus rhGDF5 plus 1,25D. (C) IHC for VDR was performed on P7, P14, P30, and P60 entheses from WT, Hyp, and C–/– mice. In all representative pictures, the enthesis region is outlined with a black box. Scale bar: 20 μm. Data are representative of 6 mice per age or genotype group.

    Article Snippet: For Western blot analyses, chondrocytes were pretreated for 0.5, 1, 4, or 18 hours with 1 × 10–8 M 1,25D prior to exposure to recombinant human GDF5 (rhGDF5) (100 ng/mL; R&D Systems) for 30 minutes.

    Techniques: Expressing, Incubation, Western Blot, Gene Expression

    Fig. 1. SDS-PAGE and densitometric analy- ses of cell layers of human tenocytes treated without ( − )/with ( + ) MMC (carrageenan) and without ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that MMC supple- mentation, at all timepoints, induced signifi- cantly ( p < 0.05) higher collagen type I depo- sition than the non-MMC groups (without or even with any GF). among the simultaneous GF supplementation to MMC, TGF 𝛽3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. among the serial GF supplementation to MMC, TGF 𝛽3 induced the highest ( p < 0.05) colla- gen type I deposition in human tenocyte cul- tures at all time points. Day 4 ( A ), Day 7 ( B ), Day 10 ( C ), Day 13 ( D ). ∗ indicates significantly ( p < 0.05) higher difference between the simul- taneous and/or serial GF supplementation to MMC and MMC alone groups. Passage 3. N = 3.

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Fig. 1. SDS-PAGE and densitometric analy- ses of cell layers of human tenocytes treated without ( − )/with ( + ) MMC (carrageenan) and without ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that MMC supple- mentation, at all timepoints, induced signifi- cantly ( p < 0.05) higher collagen type I depo- sition than the non-MMC groups (without or even with any GF). among the simultaneous GF supplementation to MMC, TGF 𝛽3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. among the serial GF supplementation to MMC, TGF 𝛽3 induced the highest ( p < 0.05) colla- gen type I deposition in human tenocyte cul- tures at all time points. Day 4 ( A ), Day 7 ( B ), Day 10 ( C ), Day 13 ( D ). ∗ indicates significantly ( p < 0.05) higher difference between the simul- taneous and/or serial GF supplementation to MMC and MMC alone groups. Passage 3. N = 3.

    Article Snippet: GF and MMC supplementation At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24- ell plates and allowed to attach for 24 h. The culture media was re- oved and replaced with culture media containing 100 μM L-ascorbic cid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis nd 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml ecombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombi- ant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human GF β3 (PeproTech EC, UK) with and without 50 μg/ml of carrageenan CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, reland).

    Techniques: SDS Page

    Fig. 2. Immunocytochemistry and relative flu- orescence intensity analyses of collagen type I of cell layers of human tenocytes treated with- out ( − )/with ( + ) MMC (carrageenan) and with- out ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that MMC supplementa- tion, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). At day 10 and 13, IGF1 in both simultaneous and serial to MMC supplementa- tion induced significantly higher ( p < 0.05) col- lagen type I deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was detected in collagen type I deposition be- tween MMC alone and PDGF 𝛽𝛽supplementa- tion in either simultaneous or serial fashion to MMC ( B ). At days 4, 10 and 13, GDF5 sup- plementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type I deposition than the MMC alone group ( C ). At day 4, 7 and 13, TGF 𝛽3 supplementation in si- multaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type I deposition than the MMC alone group ( D ). ∗

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Fig. 2. Immunocytochemistry and relative flu- orescence intensity analyses of collagen type I of cell layers of human tenocytes treated with- out ( − )/with ( + ) MMC (carrageenan) and with- out ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that MMC supplementa- tion, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). At day 10 and 13, IGF1 in both simultaneous and serial to MMC supplementa- tion induced significantly higher ( p < 0.05) col- lagen type I deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was detected in collagen type I deposition be- tween MMC alone and PDGF 𝛽𝛽supplementa- tion in either simultaneous or serial fashion to MMC ( B ). At days 4, 10 and 13, GDF5 sup- plementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type I deposition than the MMC alone group ( C ). At day 4, 7 and 13, TGF 𝛽3 supplementation in si- multaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type I deposition than the MMC alone group ( D ). ∗

    Article Snippet: GF and MMC supplementation At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24- ell plates and allowed to attach for 24 h. The culture media was re- oved and replaced with culture media containing 100 μM L-ascorbic cid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis nd 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml ecombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombi- ant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human GF β3 (PeproTech EC, UK) with and without 50 μg/ml of carrageenan CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, reland).

    Techniques: Immunocytochemistry

    Fig. 3. Immunocytochemistry and relative flu- orescence intensity analyses of collagen type III of cell layers of human tenocytes treated with- out ( − )/with ( + ) MMC (carrageenan) and with- out ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that MMC supplementa- tion, at all timepoints, induced significantly ( p < 0.05) higher collagen type III deposition than the non-MMC groups (without or even with any GF). At day 7 and, IGF1 supplementa- tion in simultaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type III deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was de- tected in collagen type III deposition between MMC alone and PDGF 𝛽𝛽supplementation in either simultaneous or serial fashion to MMC ( B ). At day 10 and 13, GDF5 supplementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( C ). At day 4 and 7, TGF 𝛽3 supplementation either simultaneously or in serial fashion to MMC and at day 13 only in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( D ). ∗ indicates sig- nificantly (at p < 0.05) higher difference be- tween the simultaneous and/or serial GF sup- plementation to MMC and MMC alone groups. Collagen type III: Green. DAPI: Blue. Scale bars: 100 𝜇m. Passage 3. N = 3.

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Fig. 3. Immunocytochemistry and relative flu- orescence intensity analyses of collagen type III of cell layers of human tenocytes treated with- out ( − )/with ( + ) MMC (carrageenan) and with- out ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that MMC supplementa- tion, at all timepoints, induced significantly ( p < 0.05) higher collagen type III deposition than the non-MMC groups (without or even with any GF). At day 7 and, IGF1 supplementa- tion in simultaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type III deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was de- tected in collagen type III deposition between MMC alone and PDGF 𝛽𝛽supplementation in either simultaneous or serial fashion to MMC ( B ). At day 10 and 13, GDF5 supplementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( C ). At day 4 and 7, TGF 𝛽3 supplementation either simultaneously or in serial fashion to MMC and at day 13 only in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( D ). ∗ indicates sig- nificantly (at p < 0.05) higher difference be- tween the simultaneous and/or serial GF sup- plementation to MMC and MMC alone groups. Collagen type III: Green. DAPI: Blue. Scale bars: 100 𝜇m. Passage 3. N = 3.

    Article Snippet: GF and MMC supplementation At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24- ell plates and allowed to attach for 24 h. The culture media was re- oved and replaced with culture media containing 100 μM L-ascorbic cid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis nd 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml ecombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombi- ant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human GF β3 (PeproTech EC, UK) with and without 50 μg/ml of carrageenan CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, reland).

    Techniques: Immunocytochemistry

    Fig. 4. Hierarchal clustering of the fold change (threshold of 3) in gene expression of human tenocytes cultured without ( − )/with ( + ) MMC (carrageenan) and without ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that at all timepoints TGF 𝛽3 alone and TGF 𝛽3 in either simultaneous or serial supplementation to CR upregulated the most and downregulated the least collagen- and tendon- related genes and upregulated the least and downregulated the most osteo-, chondro-, fibrosis- and adipose- related trans-differentiation genes in comparison to the other GFs without CR and with CR (either in simultaneous or serial fashion to the GFs). IGF1 ( A ), PDGF 𝛽𝛽( B ), GDF5 ( C ), TGF 𝛽3 ( D ). The heatmap was generated by a log transformation of the real-time PCR data presented as ΔCT = (CT miRNA – CT GAPDH) compared to without CR and without GF at each timepoint. Passage 3. Data derived by pooling six wells per sample ( N = 2).

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Fig. 4. Hierarchal clustering of the fold change (threshold of 3) in gene expression of human tenocytes cultured without ( − )/with ( + ) MMC (carrageenan) and without ( − )/with ( + ) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF 𝛽𝛽, GDF5 and TGF 𝛽3 revealed that at all timepoints TGF 𝛽3 alone and TGF 𝛽3 in either simultaneous or serial supplementation to CR upregulated the most and downregulated the least collagen- and tendon- related genes and upregulated the least and downregulated the most osteo-, chondro-, fibrosis- and adipose- related trans-differentiation genes in comparison to the other GFs without CR and with CR (either in simultaneous or serial fashion to the GFs). IGF1 ( A ), PDGF 𝛽𝛽( B ), GDF5 ( C ), TGF 𝛽3 ( D ). The heatmap was generated by a log transformation of the real-time PCR data presented as ΔCT = (CT miRNA – CT GAPDH) compared to without CR and without GF at each timepoint. Passage 3. Data derived by pooling six wells per sample ( N = 2).

    Article Snippet: GF and MMC supplementation At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24- ell plates and allowed to attach for 24 h. The culture media was re- oved and replaced with culture media containing 100 μM L-ascorbic cid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis nd 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml ecombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombi- ant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human GF β3 (PeproTech EC, UK) with and without 50 μg/ml of carrageenan CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, reland).

    Techniques: Gene Expression, Cell Culture, Comparison, Generated, Transformation Assay, Real-time Polymerase Chain Reaction, Derivative Assay

    SDS-PAGE and densitometric analyses of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). among the simultaneous GF supplementation to MMC, TGF β 3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. among the serial GF supplementation to MMC, TGF β 3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. Day 4 ( A ), Day 7 ( B ), Day 10 ( C ), Day 13 ( D ). * indicates significantly ( p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Passage 3. N = 3.

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: SDS-PAGE and densitometric analyses of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). among the simultaneous GF supplementation to MMC, TGF β 3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. among the serial GF supplementation to MMC, TGF β 3 induced the highest ( p < 0.05) collagen type I deposition in human tenocyte cultures at all time points. Day 4 ( A ), Day 7 ( B ), Day 10 ( C ), Day 13 ( D ). * indicates significantly ( p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Passage 3. N = 3.

    Article Snippet: At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24-well plates and allowed to attach for 24 h. The culture media was removed and replaced with culture media containing 100 μ M L-ascorbic acid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis and 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml recombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombinant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human TGF β 3 (PeproTech EC, UK) with and without 50 μ g/ml of carrageenan (CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, Ireland).

    Techniques: SDS Page

    Immunocytochemistry and relative fluorescence intensity analyses of collagen type I of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). At day 10 and 13, IGF1 in both simultaneous and serial to MMC supplementation induced significantly higher ( p < 0.05) collagen type I deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was detected in collagen type I deposition between MMC alone and PDGF ββ supplementation in either simultaneous or serial fashion to MMC ( B ). At days 4, 10 and 13, GDF5 supplementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type I deposition than the MMC alone group ( C ). At day 4, 7 and 13, TGF β 3 supplementation in simultaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type I deposition than the MMC alone group ( D ). * indicates significantly (at p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Collagen type I: Green, DAPI: Blue. Scale bars: 100 μm. Passage 3. N = 3.

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Immunocytochemistry and relative fluorescence intensity analyses of collagen type I of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type I deposition than the non-MMC groups (without or even with any GF). At day 10 and 13, IGF1 in both simultaneous and serial to MMC supplementation induced significantly higher ( p < 0.05) collagen type I deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was detected in collagen type I deposition between MMC alone and PDGF ββ supplementation in either simultaneous or serial fashion to MMC ( B ). At days 4, 10 and 13, GDF5 supplementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type I deposition than the MMC alone group ( C ). At day 4, 7 and 13, TGF β 3 supplementation in simultaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type I deposition than the MMC alone group ( D ). * indicates significantly (at p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Collagen type I: Green, DAPI: Blue. Scale bars: 100 μm. Passage 3. N = 3.

    Article Snippet: At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24-well plates and allowed to attach for 24 h. The culture media was removed and replaced with culture media containing 100 μ M L-ascorbic acid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis and 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml recombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombinant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human TGF β 3 (PeproTech EC, UK) with and without 50 μ g/ml of carrageenan (CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, Ireland).

    Techniques: Immunocytochemistry, Fluorescence

    Immunocytochemistry and relative fluorescence intensity analyses of collagen type III of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type III deposition than the non-MMC groups (without or even with any GF). At day 7 and, IGF1 supplementation in simultaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type III deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was detected in collagen type III deposition between MMC alone and PDGF ββ supplementation in either simultaneous or serial fashion to MMC ( B ). At day 10 and 13, GDF5 supplementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( C ). At day 4 and 7, TGF β 3 supplementation either simultaneously or in serial fashion to MMC and at day 13 only in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( D ). * indicates significantly (at p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Collagen type III: Green. DAPI: Blue. Scale bars: 100 μm. Passage 3. N = 3.

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Immunocytochemistry and relative fluorescence intensity analyses of collagen type III of cell layers of human tenocytes treated without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that MMC supplementation, at all timepoints, induced significantly ( p < 0.05) higher collagen type III deposition than the non-MMC groups (without or even with any GF). At day 7 and, IGF1 supplementation in simultaneous and serial fashion to MMC induced significantly higher ( p < 0.05) collagen type III deposition than the MMC alone group ( A ). No significant ( p > 0.05) difference was detected in collagen type III deposition between MMC alone and PDGF ββ supplementation in either simultaneous or serial fashion to MMC ( B ). At day 10 and 13, GDF5 supplementation in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( C ). At day 4 and 7, TGF β 3 supplementation either simultaneously or in serial fashion to MMC and at day 13 only in serial fashion to MMC induced significantly ( p < 0.05) higher collagen type III deposition than the MMC alone group ( D ). * indicates significantly (at p < 0.05) higher difference between the simultaneous and/or serial GF supplementation to MMC and MMC alone groups. Collagen type III: Green. DAPI: Blue. Scale bars: 100 μm. Passage 3. N = 3.

    Article Snippet: At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24-well plates and allowed to attach for 24 h. The culture media was removed and replaced with culture media containing 100 μ M L-ascorbic acid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis and 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml recombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombinant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human TGF β 3 (PeproTech EC, UK) with and without 50 μ g/ml of carrageenan (CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, Ireland).

    Techniques: Immunocytochemistry, Fluorescence

    Hierarchal clustering of the fold change (threshold of 3) in gene expression of human tenocytes cultured without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that at all timepoints TGF β 3 alone and TGF β 3 in either simultaneous or serial supplementation to CR upregulated the most and downregulated the least collagen- and tendon- related genes and upregulated the least and downregulated the most osteo-, chondro-, fibrosis- and adipose- related trans-differentiation genes in comparison to the other GFs without CR and with CR (either in simultaneous or serial fashion to the GFs). IGF1 ( A ), PDGF ββ ( B ), GDF5 ( C ), TGF β 3 ( D ). The heatmap was generated by a log transformation of the real-time PCR data presented as ΔCΤ = (CΤ miRNA – CΤ GAPDH) compared to without CR and without GF at each timepoint. Passage 3. Data derived by pooling six wells per sample ( N = 2).

    Journal: Biomaterials and Biosystems

    Article Title: Growth factor and macromolecular crowding supplementation in human tenocyte culture

    doi: 10.1016/j.bbiosy.2021.100009

    Figure Lengend Snippet: Hierarchal clustering of the fold change (threshold of 3) in gene expression of human tenocytes cultured without (−)/with (+) MMC (carrageenan) and without (−)/with (+) (either in simultaneous or in serial fashion to MMC) IGF1, PDGF ββ , GDF5 and TGF β 3 revealed that at all timepoints TGF β 3 alone and TGF β 3 in either simultaneous or serial supplementation to CR upregulated the most and downregulated the least collagen- and tendon- related genes and upregulated the least and downregulated the most osteo-, chondro-, fibrosis- and adipose- related trans-differentiation genes in comparison to the other GFs without CR and with CR (either in simultaneous or serial fashion to the GFs). IGF1 ( A ), PDGF ββ ( B ), GDF5 ( C ), TGF β 3 ( D ). The heatmap was generated by a log transformation of the real-time PCR data presented as ΔCΤ = (CΤ miRNA – CΤ GAPDH) compared to without CR and without GF at each timepoint. Passage 3. Data derived by pooling six wells per sample ( N = 2).

    Article Snippet: At passage three, tenocytes were seeded at 25,000 cells/cm 2 in 24-well plates and allowed to attach for 24 h. The culture media was removed and replaced with culture media containing 100 μ M L-ascorbic acid phosphate (Sigma Aldrich, Ireland) to induce collagen synthesis and 100 ng/ml recombinant human IGF1 (R&D Systems, UK), 50 ng/ml recombinant human PDGF ββ (PeproTech EC, UK), 100 ng/ml recombinant human GDF5 (R&D Systems, UK) or 20 ng/ml recombinant human TGF β 3 (PeproTech EC, UK) with and without 50 μ g/ml of carrageenan (CR, mixture of κ and lesser amounts of λ CR, C1013, Sigma Aldrich, Ireland).

    Techniques: Gene Expression, Cell Culture, Comparison, Generated, Transformation Assay, Real-time Polymerase Chain Reaction, Derivative Assay

    FIGURE 5 (a) Regulation of Fhl2 gene expression in micromass cultures 6 h after treatments with Wnt3A and Wnt5A (a), Tgfbeta2, and inhibitor of Smad3, SIS3 (b), and all‐trans‐retinoic acid (c). (d, e) Regulation of Fhl2 in micromass cultures 24 hr after treatment with different bone morphogenetic protein (BMP) ligands (BMP4, BMP5, BMP7, and GDF5; d) and BMP antagonists (noggin and chordin‐like 2) or the BMP inhibitor DMH1 (e). ***p < .001; **p < .01; *p < .05 versus control. ###p < .001 between the two treatments

    Journal: Journal of tissue engineering and regenerative medicine

    Article Title: Four and a half domain 2 (FHL2) scaffolding protein is a marker of connective tissues of developing digits and regulates fibrogenic differentiation of limb mesodermal progenitors.

    doi: 10.1002/term.2637

    Figure Lengend Snippet: FIGURE 5 (a) Regulation of Fhl2 gene expression in micromass cultures 6 h after treatments with Wnt3A and Wnt5A (a), Tgfbeta2, and inhibitor of Smad3, SIS3 (b), and all‐trans‐retinoic acid (c). (d, e) Regulation of Fhl2 in micromass cultures 24 hr after treatment with different bone morphogenetic protein (BMP) ligands (BMP4, BMP5, BMP7, and GDF5; d) and BMP antagonists (noggin and chordin‐like 2) or the BMP inhibitor DMH1 (e). ***p < .001; **p < .01; *p < .05 versus control. ###p < .001 between the two treatments

    Article Snippet: Fhl2 gene regulation was investigated after the following treatments: human recombinant TGFβ2 (10 ng/ml; R&D Systems); the specific inhibitor of Smad3, SIS3 (10 μM, Calbiochem); human recombinant BMP4, BMP5, BMP7, and GDF5 all at 200 ng/ml (R&D Systems); human recombinant NOGGIN at 200 ng/ml (R&D Systems); mouse recombinant chordin‐like 2 at 1200 ng/ml (R&D Systems); BMP inhibitor II, DMH1 at 4 mM (Calbiochem); human recombinant Wnt3a and Wnt5a at 150 ng/ml (R&D Systems); and all‐trans‐retinoic acid (RA) at 50 ng/ml (Sigma).

    Techniques: Gene Expression, Control